Drug data last refreshed 12h ago · AI intelligence enriched 1mo ago
Children's Advil Cold is a fixed-dose combination oral suspension containing ibuprofen (a nonsteroidal anti-inflammatory drug) and pseudoephedrine hydrochloride (a nasal decongestant). It is indicated for the temporary relief of cold symptoms in children, including fever, aches, and nasal congestion. The product addresses pediatric cold symptomatology through dual mechanism action targeting inflammation and congestion.
Product is approaching loss of exclusivity with moderate competitive pressure (30%), suggesting a mature brand team focused on defending market share against generic entry.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Positions linked to Children's Advil Cold typically focus on defending mature OTC market share, managing generic transition, and optimizing manufacturing/supply chain efficiency rather than innovation or growth. This product offers stable but limited career development given its LOE status and commodity market positioning.
Worked on CHILDREN'S ADVIL COLD at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.